Cargando…

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH

Detalles Bibliográficos
Autores principales:	Raghunathan, Sahana, Senter, D. Michael, Senter, Elizabeth, Keen, Susan, Shartle, Kaitlin, Simpson, Ross J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972415/ http://dx.doi.org/10.1016/S0735-1097(22)03082-0

Ejemplares similares

THE ASSOCIATION OF STRUCTURAL INEQUITIES AND RACE WITH OUT-OF-HOSPITAL SUDDEN DEATH DURING THE COVID-19 PANDEMIC
por: Makker, Parth, et al.
Publicado: (2021)

RISK FACTORS ASSOCIATED WITH ICU ADMISSION AND DEATH AMONG COVID-19 PATIENTS IN A LARGE ACADEMIC HEALTHCARE NETWORK
por: Meena, Richard, et al.
Publicado: (2021)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

IS HYPERTENSION (HTN) AN INDEPENDENT RISK FACTOR FOR MORTALITY IN COVID-19 PATIENTS?
por: Mughal, Mohsin, et al.
Publicado: (2021)

PREDICTORS OF DEATH AND CARDIOPULMONARY OUTCOMES AMONG HOSPITALIZED COVID-19 PATIENTS IN LATIN AMERICA
por: Burgos, Jaime Andrés Ibarra, et al.
Publicado: (2023)

RISK FACTORS OF ARTERIAL THROMBOEMBOLISM IN HOSPITALIZED COVID-19 PATIENTS: A MULTICENTER COHORT STUDY
por: Lee, Yi, et al.
Publicado: (2022)

RISK FACTORS FOR COVID-19 RELATED MORTALITY- A SYSTEMATIC REVIEW AND META-ANALYSIS OF 26 STUDIES AND 9690 PATIENTS
por: Goel, Sunny, et al.
Publicado: (2021)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

THE ROLE OF ABO BLOOD GROUP TYPING IN RISK STRATIFYING PATIENTS WITH THE NOVEL CORONAVIRUS 2019-NCOV
por: Shadid, Husam, et al.
Publicado: (2021)

TRENDS IN ACUTE CARDIOVASCULAR DISEASE ADMISSIONS BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC SURGE IN BOSTON
por: Diamond, Jamie Elizabeth, et al.
Publicado: (2021)

PREDICTION OF HOSPITALIZATION AND ICU ADMISSION FOR ONTARIO COVID-19 PATIENTS WITH CARDIAC COMORBIDITIES
por: Kearney, Abigail, et al.
Publicado: (2022)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

IMPACT OF THROMBOPROPHYLACTIC STRATEGY ON BLEEDING RISK AMONG IN- AND OUTPATIENTS WITH COVID-19
por: Svet, Mark, et al.
Publicado: (2021)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

OUTCOMES AND READMISSION RISK OF CRITICALLY ILL COVID-19 PATIENTS WITH CARDIOVASCULAR OUTCOMES
por: Manjappachar, Nirmala, et al.
Publicado: (2022)

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH SEVERE COVID-19 DISEASE
por: Solorzano, Juan, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

RISK OF RECURRENT MYOCARDITIS FOLLOWING COVID-19 MRNA VACCINATION IN ADULTS WITH PRIOR HISTORY
por: Simone, Anthony, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

COVID-19 RISK PERCEPTION AND IDENTIFICATION OF APPROPRIATE MITIGATION STRATEGIES AMONG ADULTS WITH CONGENITAL HEART DEFECTS
por: Jackson, Jamie, et al.
Publicado: (2022)

RISK OF CARDIOVASCULAR COMPLICATIONS IN ETHNIC MINORITIES INFECTED WITH COVID-19 - EXPERIENCE IN A MID-SIZED MIDWESTERN CITY
por: Desai, Viral, et al.
Publicado: (2021)

DO ELECTIVE CARDIAC PROCEDURES INCREASE THE RISK OF SYMPTOMATIC COVID-19 TRANSMISSION WITH CURRENT HOSPITAL PRECAUTIONARY MEASURES?
por: Suhotliv, Amy, et al.
Publicado: (2021)

ECHOCARDIOGRAPHIC ABNORMALITIES ARE COMMON AMONG PATIENTS WITH COVID-19 INFECTION AND INDEPENDENTLY CONFER INCREASED RISK OF IN-HOSPITAL MORTALITY
por: Homan, Edwin A., et al.
Publicado: (2021)

RETURN TO PLAY EVALUATION POST COVID - LONGITUDINAL EXPERIENCE IN CARDIAC RISK ASSESSMENT AT A DIVISION I ATHLETIC PROGRAM
por: Sivalokanathan, Sanjay, et al.
Publicado: (2023)

PSYCHOSOCIAL FACTORS AMONG A SAMPLE OF CARDIAC REHABILITATION PATIENTS THAT HAVE GONE THROUGH COVID19 INFECTION
por: Coello, Mercedes, et al.
Publicado: (2022)

EVALUATION OF FACTORS ASSOCIATED WITH MORTALITY AMONGST PATIENTS ADMITTED TO A TERTIARY CARE MEDICAL CENTER FOR COVID-19 INFECTION
por: Samuel, Anish, et al.
Publicado: (2021)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

OUTCOMES OF ATTEMPTED RESUSCITATION WITH ACLS IN COVID-19 PATIENTS REQUIRING ICU ADMISSION
por: Khorsandi, Michael, et al.
Publicado: (2023)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

CARDIOMYOPATHIC GENE MUTATIONS ALTER ACE2 EXPRESSION AND INFECTIVITY OF SARS-COV-2 IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
por: Kontorovich, Amy, et al.
Publicado: (2021)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v6nc3hvugasji2em981r5v2fk5